Recent Advances in Parathyroid Disease and Parathyroid Hormone Assays

Clinical Leadership and Management Review

Volumn 16, Issue 3, 2002, Pages 187-191

  Garon, Jack E ^a   Liu, Ning ^b  

^a Mt Sinai Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DISEASE MANAGEMENT; HUMAN; PARATHYROID DISEASE; PHYSIOLOGY; RADIOIMMUNOASSAY; UNITED STATES;

CALCIUM; DISEASE MANAGEMENT; HUMANS; KIDNEY FAILURE, CHRONIC; PARATHYROID DISEASES; PARATHYROID HORMONE; RADIOIMMUNOASSAY; UNITED STATES;

EID: 0036580401     PISSN: 15273954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Juppner HW, Gardella TJ, Brown EM, et al. Parathyroid hormone and parathyroid hormone-regulated peptide in the regulation of calcium homeostasis and bone development. In: Degroot LJ, Jameson JL (editors). Endocrinology. 4th ed. Philadelphia: WB Saunders, 2001:969-998.
2. Endres DB, Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER (editors). Tietz text book of clinical chemistry. 2nd ed. Philadelphia: WB Saunders, 1994:1913-1917.
3. Birnbaum J, Van Herle AJ. Immunoheterogeneity of parathyroid hormone in parathyroid cysts: diagnostic implications. J Endocrinol Invest, 1989;12(11):831-836.
4. Kao PC, van Heerden JA, Grant CS, et al. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc, 1992;67(7):637-645.
5. Brossard JH, Cloutier M, Roy L, et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab, 1996;81(11):3923-3929.
6. Gao P, Scheibel S, D'Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001;16(4):605-614.
7. Slatopolsky E, Finch J, Clay P, et al. A novel mechanism for skeletal resistance in uremia. Kidney Int, 2000;58(2):753-761.
8. Lepage R, Roy L, Brossard JH, et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem, 1998;44(4):805-809.
9. Wilson JD, Foster DW, Kronenberg HM, Larse PR. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998:1156-1189.
10. Silverberg SJ, Bilezikian JP. Primary hyperparathyroidism. In: Degroot LJ, Jameson JL (editors). Endocrinology. 4th ed. Philadelphia: WB Saunders, 2001:1075-1089.
11. Silverberg SH, Brown IN, Bilezikian IP, et al. A new highly sensitive assay for parathyroid hormone in primary hyperparathyroidism. Int Bone Mineral Res, 2000;15:s167.
12. Le HL, Norton JA. Surgical management of hyperparathyroidism. In: Degroot LJ, Jameson JL (editors). Endocrinology. 4th ed. Philadelphia: WB Saunders, 2001:1111-1120.
13. Irvin GL 3rd, Deriso GT 3rd. A new, practical intraoperative parathyroid hormone assay. Am J Surg, 1994;168(5):466-468.
14. Patel PC, Pellitteri PK, Patel NM, Fleetwood MK. Use of a rapid intraoperative parathyroid hormone assay in the surgical management of parathyroid disease. Arch Otolaryngol Head Neck Surg, 1998;124(5):559-562.
15. Bergenfelz A, Isaksson A, Lindblom P, et al. Measurement of parathyroid hormone in patients with primary hyperparathyroidism undergoing first and reoperative surgery. Br J Surg, 1998;85(8): 1129-1132.
16. Llach F, Velasquez Forero F. Secondary hyperparathyroidism in chroni-renal failure: pathogenic and clinical aspects. Am J Kidney Dis (review), 2001;38(5 supplement 5):S20-33.
17. Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D. Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis, 2001;38(5 supplement 5):S51-56.
18. Brown AJ. Therapeutic uses of vitamin D analogues. Am J Kidney Dis (review), 2001;38(5 supplement 5):S3-S19.
19. Martin KJ, Gonzalez EA. Vitamin D analogues for the management of secondary hyperparathyroidism. Am J Kidney Dis (review), 2001;38(5 supplement 5):S34-40.
20. Fournier A, Oprisiu R, Hottelart C, et al. Renal osteodystrophy in dialysis patients: diagnosis and treatment. Artif Organs (review), 1998;22(7):530-557.
21. Llach F, Yudd M. Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis, 2001; 38(5 supplement 5):S45-50.
22. Monier-Faugere MC, Geng Z, Mawad H, et al. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int, 2001;60(4):1460-1468.
23. Monier-Faugere MC, Geng Z, Malluche HH. The 1-84:7-84 ratio for determination of bone turnover in chronically dialyzed patients. ASN Abstracts, 2000;A2924.
24. Levine MA. Hypoparathroidism and pseudohypoparathyroidism. In: Degroot LJ, Jameson JL (editors). Endocrinology. 4th ed. Philadelphia: WB Saunders, 2001:1133-1148.